Maverick Capital

Founded in 1993, Maverick Capital is a global investment firm with offices across New York, San Francisco, London, Hong Kong, Philadelphia, and Dallas. The firm primarily manages private investment funds for qualified investors, focusing on long/short hedged equity strategies to grow and preserve capital. Since its inception, Maverick has strategically invested in private companies with disruptive business models or technologies, actively partnering with portfolio teams to build businesses.

Suzanne Guthrie

CFO

Andrew Homan

Managing Director

Jéssica Leão

Principal

Prateesh Maheshwari

Managing Director

Soren Sudhof

Managing Director

Past deals in Personal Health

Nourish

Series B in 2025
Nourish improves people's health by facilitating easy access to clinical-grade nutrition care via its telehealth platform. It connects users with registered dietitians for personalized assessments, treatment plans, ongoing support, and insurance coverage.

Daymark Health

Seed Round in 2025
Daymark Health is a healthcare company specializing in supportive care services for cancer patients. It connects primary care physicians, oncologists, and care teams to provide virtual and home-based care, symptom management, care navigation, social support, and mental health services. These services are delivered by nurse practitioners, social workers, and health partners, ensuring comprehensive, personalized care that addresses both medical and non-medical needs throughout the patient's treatment journey.

Esperto Medical

Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostics for both hospital and remote patient monitoring. The company utilizes innovative resonance sonomanometry technology, which employs acoustic stimulation to provide continuous and noninvasive blood pressure measurements without the need for calibration. By enabling round-the-clock monitoring of vital signs, Esperto Medical’s devices aim to enhance accessibility to medical care through automation, allowing patients to effectively manage their health from home or within clinical settings.

Nourish

Series A in 2024
Nourish improves people's health by facilitating easy access to clinical-grade nutrition care via its telehealth platform. It connects users with registered dietitians for personalized assessments, treatment plans, ongoing support, and insurance coverage.

Oula Health

Series B in 2024
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

PrognomiQ

Venture Round in 2022
PrognomiQ is a technology company focused on transforming early disease detection and treatment through multi-omics data. It generates proteomic, genomic, and metabolomic data to provide insights into complex diseases and to improve patient outcomes. The company develops advanced test products that apply multi-omics data to detect cancers and other conditions earlier, complementing traditional diagnostics and supporting monitoring of disease recurrence. By integrating proteomic data with broader health data, PrognomiQ aims to enable clinicians to diagnose more accurately and tailor interventions, ultimately advancing preventive and precision medicine.

Belong Health

Series A in 2021
Belong Health collaborates with local health plans to deliver regionally tailored, personalized care to a growing community of individuals eligible for Medicare Advantage and dual-eligible special needs plans.

Belong Health

Seed Round in 2021
Belong Health collaborates with local health plans to deliver regionally tailored, personalized care to a growing community of individuals eligible for Medicare Advantage and dual-eligible special needs plans.

Cityblock

Series C in 2021
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Cityblock

Series C in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

PrognomiQ

Venture Round in 2020
PrognomiQ is a technology company focused on transforming early disease detection and treatment through multi-omics data. It generates proteomic, genomic, and metabolomic data to provide insights into complex diseases and to improve patient outcomes. The company develops advanced test products that apply multi-omics data to detect cancers and other conditions earlier, complementing traditional diagnostics and supporting monitoring of disease recurrence. By integrating proteomic data with broader health data, PrognomiQ aims to enable clinicians to diagnose more accurately and tailor interventions, ultimately advancing preventive and precision medicine.

Decent

Series A in 2020
Decent Inc. is a health insurance provider based in Mill Valley, California, that focuses on offering affordable medical insurance plans tailored for self-employed professionals. Founded in 2018, the company aims to improve healthcare access by aligning incentives to enhance health outcomes and reduce costs. One of its key offerings is the Trailblazer Plan, a comprehensive health plan designed specifically for freelancers. By prioritizing the needs of its members, Decent seeks to create a more effective and personalized healthcare experience.

Cityblock

Series B in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Remrise

Seed Round in 2019
Remrise, Inc. is a health and wellness company founded in 2018 and headquartered in San Francisco, California. The company specializes in personalized sleep aids that utilize drug-free, plant-based ingredients to enhance sleep quality. Customers begin their experience by taking a quiz that helps identify their specific sleep challenges, allowing Remrise to provide tailored sleep formulas. The key ingredients in these formulas include Reishi, Spine Date Seed, and L-Theanine. Additionally, Remrise offers a user-friendly application for tracking sleep patterns, helping individuals monitor their progress over time. The company focuses on integrating both Eastern and Western herbal traditions to support holistic health and improve overall well-being.

Cityblock

Series B in 2019
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Cityblock

Series A in 2018
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

ListRunner

Venture Round in 2017
ListRunner Inc., headquartered in Mountain View, California, offers a secure, regulatory-compliant digital platform for clinical teams to manage patient care information. Its solution enables clinicians to access and update records on various devices, reducing administrative tasks and enhancing patient care focus. The platform also ensures patient health information security and serves medical students and residents individually.

Limbix

Seed Round in 2016
Limbix is a company dedicated to developing prescription digital therapeutics for adolescent mental health. Their flagship product, SparkRx, is an evidence-based, clinically validated tool designed to treat depression and anxiety in teenagers. Limbix combines clinical expertise with technological innovation to deliver effective mental health treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.